Methenmadinone acetate (original) (raw)
- Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone. MMA given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays. Analogues of methenmadinone acetate include methenmadinone caproate (MMC), which was studied in combination with estradiol valerate as a combined injectable contraceptive (tentative brand name Lutofollin); chlormethenmadinone acetate (chlorsuperlutin; SCH-12600; 6-chloro-MMA), which has been used in combination with mestranol in birth control pills (brand names Biogest, Sterolibrin, Antigest B) and in veterinary medicine (brand name Agelin); bromethenmadinone acetate (bromsuperlutin; 6-bromo-MMA), which was assessed but was never marketed; and melengestrol acetate (methylsuperlutin; 6-methyl-MMA), which is used in veterinary medicine. (en)
- Superlutin, Antigest (en)
- 805-84-5
- KUR23M82TZ
- 188952
- 58499837 (xsd:integer)
- 10746 (xsd:nonNegativeInteger)
- 1113808066 (xsd:integer)
- dbr:Progesterone_(medication)
- dbr:Progestin
- dbr:Progestogen_(medication)
- dbr:Progestogen_ester
- dbr:Methenmadinone
- dbr:Veterinary_medicine
- dbr:Structural_analog
- dbr:List_of_progestogen_esters
- dbr:16-Methylene-17α-hydroxyprogesterone_acetate
- dbc:Abandoned_drugs
- dbc:Acetate_esters
- dbc:Diketones
- dbc:Pregnanes
- dbc:Progestogens
- dbc:Vinylidene_compounds
- dbr:Melengestrol_acetate
- dbr:Ester
- dbr:Oral_administration
- dbc:Progestogen_esters
- dbr:Chlormethenmadinone_acetate
- dbr:Birth_control_pill
- dbr:Acetate
- dbr:Czechoslovakia
- dbr:Estradiol_valerate
- dbr:Bromethenmadinone_acetate
- dbr:Bioassay
- dbr:Mestranol
- dbr:Methenmadinone_caproate
- dbr:Combined_injectable_contraceptive
- dbr:Parenteral
- 24 (xsd:integer)
- 805 (xsd:integer)
- 164183 (xsd:integer)
- 30 (xsd:integer)
- [-17-Acetyl-10,13-dimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate (en)
- 4 (xsd:integer)
- 188952 (xsd:integer)
- CC[C@]1OCC (en)
- 1 (xsd:integer)
- UXRDAJMOOGEIAQ-CKOZHMEPSA-N (en)
- Superlutin; Superlutine; MMA; Methylenedehydroacetoxyprogesterone; MDAP; 17α-Hydroxy-16-methylene-δ6-progesterone 17α-acetate; 17α-Acetoxy-16-methylenepregna-4,6-diene-3,20-dione (en)
- Superlutin, Antigest (en)
- KUR23M82TZ (en)
- 235 (xsd:integer)
- dbt:About
- dbt:Drugbox
- dbt:Genito-urinary-drug-stub
- dbt:Progesterone_receptor_modulators
- dbt:Reflist
- dbt:Short_description
- dbt:Steroid-stub
- dbt:Progestogens_and_antiprogestogens
- dbc:Abandoned_drugs
- dbc:Acetate_esters
- dbc:Diketones
- dbc:Pregnanes
- dbc:Progestogens
- dbc:Vinylidene_compounds
- dbc:Progestogen_esters
- Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone. MMA given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays. (en)
- Methenmadinone acetate (en)
- wikidata:Methenmadinone acetate
- http://ckb.dbpedia.org/resource/میسێنمادینۆن_ئاستەیت
- dbpedia-vi:Methenmadinone acetate
- https://global.dbpedia.org/id/2YujW
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
- dbr:Progestogen_(medication)
- dbr:Methenmadinone
- dbr:List_of_progestogen_esters
- dbr:List_of_progestogens
- dbr:16-Methylene-17α-hydroxyprogesterone_acetate
- dbr:Melengestrol_acetate
- dbr:Bromethenmadinone_acetate
- dbr:C24H30O4
- dbr:Methylenedehydroacetoxyprogesterone
- dbr:Antigest
- dbr:Methenmadinone_caproate
- dbr:Segesterone_acetate
- dbr:MDAP_(disambiguation)
- dbr:MMA_(disambiguation)
- dbr:MDAP
- dbr:Superlutin
- dbr:Superlutine
is owl:differentFrom of
is foaf:primaryTopic of